SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-024200
Filing Date
2024-02-14
Accepted
2024-02-14 20:26:37
Documents
1
Group Members
BONG KOHNIMISH SHAHVENROCK HEALTHCARE CAPITAL PARTNERS EG, L.P.VHCP CO-INVESTMENT HOLDINGS III, LLCVHCP MANAGEMENT EG, LLCVHCP MANAGEMENT III, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm246235d5_sc13ga.htm SC 13G/A 158612
  Complete submission text file 0001104659-24-024200.txt   160517
Mailing Address 530 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10036
Business Address 530 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10036 212-444-4100
Venrock Healthcare Capital Partners III, L.P. (Filed by) CIK: 0001738048 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma, Inc. (Subject) CIK: 0001990550 (see all company filings)

IRS No.: 932892120 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-94206 | Film No.: 24641640
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)